Logo image of MRD.CA

MELCOR DEVELOPMENTS LTD (MRD.CA) Stock Fundamental Analysis

TSX:MRD - CA5854671032 - Common Stock

15.24 CAD
0 (0%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

5

MRD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 30 industry peers in the Real Estate Management & Development industry. MRD has an excellent financial health rating, but there are some minor concerns on its profitability. MRD has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year MRD was profitable.
MRD had a positive operating cash flow in the past year.
Each year in the past 5 years MRD has been profitable.
In the past 5 years MRD always reported a positive cash flow from operatings.
MRD.CA Yearly Net Income VS EBIT VS OCF VS FCFMRD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

With a Return On Assets value of 1.26%, MRD perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
MRD has a Return On Equity (2.07%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 4.50%, MRD is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
MRD had an Average Return On Invested Capital over the past 3 years of 3.82%. This is below the industry average of 7.59%.
The last Return On Invested Capital (4.50%) for MRD is above the 3 year average (3.82%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.26%
ROE 2.07%
ROIC 4.5%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
MRD.CA Yearly ROA, ROE, ROICMRD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

1.3 Margins

MRD has a Profit Margin (7.35%) which is comparable to the rest of the industry.
MRD's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 35.28%, MRD is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Operating Margin of MRD has grown nicely.
MRD has a Gross Margin of 45.96%. This is comparable to the rest of the industry: MRD outperforms 50.00% of its industry peers.
MRD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 35.28%
PM (TTM) 7.35%
GM 45.96%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
MRD.CA Yearly Profit, Operating, Gross MarginsMRD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MRD is destroying value.
MRD has less shares outstanding than it did 1 year ago.
MRD has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MRD has been reduced compared to a year ago.
MRD.CA Yearly Shares OutstandingMRD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MRD.CA Yearly Total Debt VS Total AssetsMRD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 1.59, we must say that MRD is in the distress zone and has some risk of bankruptcy.
MRD has a better Altman-Z score (1.59) than 66.67% of its industry peers.
The Debt to FCF ratio of MRD is 4.99, which is a neutral value as it means it would take MRD, 4.99 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.99, MRD belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
MRD has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.44, MRD is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.99
Altman-Z 1.59
ROIC/WACC0.57
WACC7.88%
MRD.CA Yearly LT Debt VS Equity VS FCFMRD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

MRD has a Current Ratio of 3.81. This indicates that MRD is financially healthy and has no problem in meeting its short term obligations.
MRD has a Current ratio of 3.81. This is amongst the best in the industry. MRD outperforms 90.00% of its industry peers.
A Quick Ratio of 3.81 indicates that MRD has no problem at all paying its short term obligations.
The Quick ratio of MRD (3.81) is better than 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.81
Quick Ratio 3.81
MRD.CA Yearly Current Assets VS Current LiabilitesMRD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2

3. Growth

3.1 Past

MRD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -66.36%.
The Earnings Per Share has been decreasing by -0.67% on average over the past years.
Looking at the last year, MRD shows a small growth in Revenue. The Revenue has grown by 6.57% in the last year.
MRD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.94% yearly.
EPS 1Y (TTM)-66.36%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%-61.9%
Revenue 1Y (TTM)6.57%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRD.CA Yearly Revenue VS EstimatesMRD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
MRD.CA Yearly EPS VS EstimatesMRD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.05 indicates a rather expensive valuation of MRD.
The rest of the industry has a similar Price/Earnings ratio as MRD.
MRD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.06.
Based on the Price/Forward Earnings ratio of 7.58, the valuation of MRD can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MRD indicates a rather cheap valuation: MRD is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, MRD is valued rather cheaply.
Industry RankSector Rank
PE 19.05
Fwd PE 7.58
MRD.CA Price Earnings VS Forward Price EarningsMRD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MRD is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, MRD is valued cheaper than 93.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.2
EV/EBITDA 7.58
MRD.CA Per share dataMRD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of MRD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

MRD has a Yearly Dividend Yield of 3.41%.
MRD's Dividend Yield is a higher than the industry average which is at 3.21.
Compared to an average S&P500 Dividend Yield of 2.45, MRD pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.41%

5.2 History

The dividend of MRD decreases each year by -2.57%.
MRD has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-2.57%
Div Incr Years0
Div Non Decr Years0
MRD.CA Yearly Dividends per shareMRD.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

51.91% of the earnings are spent on dividend by MRD. This is a bit on the high side, but may be sustainable.
MRD's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP51.91%
EPS Next 2YN/A
EPS Next 3YN/A
MRD.CA Yearly Income VS Free CF VS DividendMRD.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M
MRD.CA Dividend Payout.MRD.CA Dividend Payout, showing the Payout Ratio.MRD.CA Dividend Payout.PayoutRetained Earnings

MELCOR DEVELOPMENTS LTD

TSX:MRD (9/5/2025, 7:00:00 PM)

15.24

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-06 2025-11-06
Inst Owners8.77%
Inst Owner ChangeN/A
Ins Owners14.05%
Ins Owner ChangeN/A
Market Cap459.64M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.41%
Yearly Dividend0.44
Dividend Growth(5Y)-2.57%
DP51.91%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-15 2025-09-15 (0.13)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.05
Fwd PE 7.58
P/S 1.31
P/FCF 4.2
P/OCF 3.59
P/B 0.37
P/tB 0.37
EV/EBITDA 7.58
EPS(TTM)0.8
EY5.25%
EPS(NY)2.01
Fwd EY13.19%
FCF(TTM)3.63
FCFY23.82%
OCF(TTM)4.24
OCFY27.84%
SpS11.62
BVpS41.23
TBVpS41.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.26%
ROE 2.07%
ROCE 6.24%
ROIC 4.5%
ROICexc 4.64%
ROICexgc 4.79%
OM 35.28%
PM (TTM) 7.35%
GM 45.96%
FCFM 31.23%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
ROICexc(3y)3.93%
ROICexc(5y)3.72%
ROICexgc(3y)4.06%
ROICexgc(5y)3.84%
ROCE(3y)5.31%
ROCE(5y)5.03%
ROICexcg growth 3Y4.23%
ROICexcg growth 5Y17.72%
ROICexc growth 3Y4.16%
ROICexc growth 5Y17.7%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
F-Score7
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.99
Debt/EBITDA 4.37
Cap/Depr 1515.14%
Cap/Sales 5.28%
Interest Coverage 250
Cash Conversion 102.48%
Profit Quality 425.01%
Current Ratio 3.81
Quick Ratio 3.81
Altman-Z 1.59
F-Score7
WACC7.88%
ROIC/WACC0.57
Cap/Depr(3y)1460.36%
Cap/Depr(5y)1587.21%
Cap/Sales(3y)6.3%
Cap/Sales(5y)7.47%
Profit Quality(3y)95.67%
Profit Quality(5y)124.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-66.36%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%-61.9%
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.57%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%2%
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.75%
EBIT growth 3Y4.12%
EBIT growth 5Y17.48%
EBIT Next Year-3.66%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1768.67%
FCF growth 3Y18.66%
FCF growth 5Y52.08%
OCF growth 1Y941.33%
OCF growth 3Y10.64%
OCF growth 5Y25.86%